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Abstract 
Biallelic mutations in the IGHMBP 2 have been associated with two distinct phenotypes: spinal muscular atrophy with respiratory distress 
type 1 (SMARD1) and CMT2S. We describe a patient who developed progressive muscle weakness and wasting in her upper and lower 
limbs from infancy. She developed respiratory involvement at age 9, eventually requiring 24-h non-invasive ventilation, and severe autonomic 
dysfunction restricted to the gastrointestinal tract. Neurophysiological studies at age 27 years revealed absent sensory and motor responses 
and severe chronic denervation changes in proximal muscles of the upper limbs. Targeted multigene panel sequencing detected a novel 
homozygous missense variant in the IGHMBP2 gene (c.1325A > G; p.Tyr442Cys). This variant was validated by Sanger sequencing and 
co-segregation analysis confirmed that both parents were asymptomatic heterozygous carriers. This case report confirms that IGHMBP2 
related disorders can result in a severe peripheral neuropathy with gastrointestinal autonomic dysfunction requiring parenteral nutrition. 
© 2018 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 























Autosomal recessive mutations in the immunoglobulin
μ-binding protein 2 gene ( IGHMBP2 ) have been associated
with two distinct phenotypes: spinal muscle atrophy with
respiratory distress type 1 (SMARD1) and, more recently,
Charcot-Marie-Tooth disease type 2S (CMT2S). In SMARD1,
degeneration of alpha motor neurons of the spinal cord results
in diaphragmatic paralysis and distal muscular atrophy. Sen-
sory and autonomic nerves are also affected in some patients.
The disorder usually starts in infancy and early death due to
respiratory distress is a hallmark of the disease, although pa-
tients with milder phenotypes (later onset and survival until∗ Corresponding author. 
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( http://creativecommons.org/licenses/by/4.0/ ) 5–20 years of age) have been described [1,2] . In contrast,
atients with CMT2S develop an axonal neuropathy man-
festing with slowly progressive, distal-predominant muscle
eakness and sensory loss with preserved respiratory function
3,4] . 
We describe a case of motor and sensory axonal neu-
opathy associated with respiratory involvement and severe
astrointestinal organ-specific autonomic dysfunction due to
 novel missense mutation in IGHMBP2 , demonstrating that
GHMBP2 related disorders can result in a severe peripheral
europathy with enteral autonomic dysfunction. 
. Case report 
The patient was evaluated in the inherited neuropathy clinic
n the Centre for Neuromuscular Diseases, National Hospital
or Neurology and Neurosurgery, London, UK. Written in-ss article under the CC BY license. 
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Fig. 1. Clinical images of the proband. Photographs of the patient’s legs, arms and trunk show severe wasting distally and proximally in upper and lower 













a  ormed consent was obtained for participation in the study and
or publication of images. Methods for whole exome sequenc-
ng (WES), targeted multigene panel and Sanger sequencing
re provided in the Supplementary Material. Nerve conduc-
ion studies, EMG and nerve biopsy were performed using
tandard methods. This study was approved by the local re-
earch ethics committee. s  
w  .1. Clinical history and phenotype 
The patient was the eldest daughter of two siblings born
o consanguineous healthy parents of Iranian origin. Her fam-
ly history was unremarkable. She presented with hypotonia
nd delayed walking during infancy. Despite this, she was
ble to walk independently until 4 years of age, when she
tarted to use ankle-foot orthoses. By 6 years of age, she was
heelchair-bound. Following an episode of pneumonia at 9


































































t  years of age, she was started on nocturnal non-invasive ven-
tilation and over the subsequent months, she became 24 h
ventilator dependent. She reported no sensory or urinary
symptoms, abnormal sweating or vasomotor symptoms. 
She developed gastrointestinal symptoms in the first
decade of life characterized by abdominal bloating, infrequent
bowel movements and constipation. Additional gastrointesti-
nal symptoms developed over the following years, including
excessive saliva, dysphagia and odynophagia eventually re-
sulting in intermittent nasogastric tube placement to relieve
the gastric gaseous distension. 
Unfortunately, her gastrointestinal symptoms gradually
worsened and, at age 14 years, she developed recurrent
episodes of acute bowel distension affecting her respiratory
capacity and requiring more frequent nasogastric tube place-
ment. At age 27 years, a percutaneous endoscopic gastros-
tomy (PEG) was performed from which 1–3 l of gastric
content was drained per day because of gastroparesis and slow
bowel function. 
At age 28 years, oesophageal intraluminal impedance
testing showed excessive gastroesophageal reflux. Anorectal
physiology studies confirmed normal sphincter function and
rectal sensation but despite this, her constipation worsened
to the extent she required an enema every other day. Proki-
netic medications had limited effect on her symptoms and her
weight decreased. At age 30 years, she was started on total
parenteral nutrition. 
Examination at 27 years of age revealed severe kyphoscol-
iosis ( Fig. 1 ). Cranial nerve examination, including eye move-
ments, tongue and palate, was normal. There was mild neck
flexion weakness. Her upper and lower limbs were wasted
proximally and distally and she was severely weak globally
with Medical Research Council (MRC) grades for shoulder
adduction 4 + /5, elbow flexion and extension 1/5 and no
movement of the intrinsic hand muscles or in the lower limbs.
Deep tendon reflexes were absent and plantar responses were
mute. Pinprick sensation was normal throughout. Vibration
sense was absent at the toes and ankles and proprioception
was absent at the toes. p  
r
Fig. 2. Sural nerve biopsy. Semi-thin resin sections from the patient’s sural nerve
fuchsin (MBA-BF). The nerve fascicles in the patient’s biopsy in comparison with
small fibre size and complete absence of large normally myelinated fibres across 
of demyelinating and remyelinating process. There were occasional clusters of regSubsequent examinations confirmed progression of the mo-
or and sensory deficits. Nerve conduction studies performed
t age 27 years revealed absent sensory and motor responses
hroughout. Needle EMG showed severe chronic denervation
n proximal muscles of the upper limbs (biceps and deltoid).
.2. Genetics studies 
Targeted Sanger sequencing of MFN2 , MPZ , LMNA , MT-
TP6 and MT-ATP8 genes revealed no pathogenic mutations.
iven the atypical phenotype, we performed whole exome se-
uencing (WES) which revealed a novel heterozygous variant
n IGHMBP2 (c.1325A > G; p.Tyr442Cys). WES coverage of
ome genes involved in hereditary neuropathy was low (Sup-
lementary Table 1) and we therefore decided to proceed with
argeted multi-gene panel testing to confirm the absence of
utations in common neuropathy-related genes. Interestingly,
he targeted multi-gene panel detected the same variant in
GHMBP2 detected by WES but in homozygosity (see Sup-
lementary Table 2 for genes included and alignment statis-
ics). In silico analyses revealed that, this variant involved
n evolutionarily conserved amino acid, and was predicted
o be pathogenic (Supplementary Material). The homozygous
ariant was validated by Sanger sequencing and the analysis
f parental DNA samples confirmed that both parents were
eterozygous carriers. 
.3. Nerve biopsy at age 3 
All fascicles in the biopsy were small. Nerve fibres across
he fascicles were small and moderately thinly myelinated.
here was no evidence of ongoing active axonal degenera-
ion or demyelination and no inflammatory infiltrates were
bserved ( Fig. 2 ). Teased fibre preparation showed uni-
ormly short internodes suggesting some regeneration. Elec-
ronic microscopy revealed some myelinated fibres with redu-
licated basement membranes and a few small clusters of
egeneration.  (A) and age-matched control (B), stained with methylene blue azure basic 
 the control were of very small size. Image A shows reduced fibre density, 
the fascicles. There was no evidence of active axonal degeneration or signs 
eneration (A, arrow). Scale bar (A and B): 25 μm. 
























































































 . Discussion 
We describe a patient with childhood onset autosomal
ecessive motor and sensory neuropathy with severe organ-
pecific autonomic dysfunction due to a novel IGHMBP2 mis-
ense variant. The mutation was miscalled as a heterozygous
llele on whole exome sequencing due to poor coverage but
as detected in homozygosity using a targeted gene panel. 
The present case has features that diverge from classical
MARD1 and CMT2S phenotypes. In contrast to SMARD1,
n which most patients require assisted ventilation within the
rst year of life and die within the first decade of life, our pa-
ient developed respiratory involvement requiring non-invasive 
entilation at age 9 years and is still alive in her 30 s. Sensory
nvolvement and autonomic dysfunction, including excessive 
weating, tachycardia, constipation and bladder dysfunction, 
ave been described in patients with SMARD1 but also in pa-
ients with CMT2S due to IGHMBP2 mutations. Our patient’s
henotype is therefore more typical of a severe CMT2S phe-
otype within the spectrum of IGHMBP2 related disorders. 
It is not clear why our patient has autonomic dysfunc-
ion restricted to the gastrointestinal tract. To our knowledge,
here have been no studies of the enteric plexus in the NMD
ouse or in post mortem tissue of patients with SMARD1 or
MT2S. Autonomic involvement in patients with IGHMBP2 -
elated disorders has been previously described. Jedrzejowska
t al. reported five SMARD1 patients from four different
amilies with autonomic dysfunction, including mild-to-severe 
xcessive sweating, tachycardia, constipation and bladder dys-
unction [5] . Schottmann et al. reported two siblings with
MT2S and progressive autonomic features including gas-
rointestinal and bladder dysfunction in association with an
xonal sensorimotor neuropathy without respiratory distress,
ne of whom required surgery for achalasia at age 18 years
4] . It’s possible that the patient has more widespread au-
onomic dysfunction, however, due to the patient’s severe
isability we were unable to undertake more extensive au-
onomic function testing. 
IGHMBP2 encodes a protein belonging to the putative he-
icase superfamily. It is expressed in developing and adult
uman brain, with high expression in the cerebellum [3] . It
s functionally linked to translation and may be a component
f the translational machinery [6,7] . 
We suggest that mutations in IGHMBP2 may cause an
arly onset severe sensory motor axonal neuropathy in asso-
iation with severe organ specific autonomic neuropathy af-
ecting the gastrointestinal tract. 
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